Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Veriheal

AUGUST 24, 2023

Christopher Simpson, a deputy director at the Pacific Northwest Agricultural Safety and Health Center, believes that overall, the risk of DDE in cannabis is likely low. “To There just isn’t experimental data available,” Simpson said. There just isn’t experimental data available,” Simpson said.

Data 83

Data Safety Extraction Cannabis 83

Veriheal

JULY 25, 2023

Quest Diagnostics started analyzing yearly workplace drug testing data 25 years ago in 1988, and the result of their recent study was published on May 18. However, it is important to note that Quest Diagnostics amphetamines data does not separate prescribed medications like Adderall from illicit drug use.

Safety 75

Safety Data Recreational Marijuana 75

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

NOVEMBER 14, 2019

million adults are now using “street cannabis ” to treat the symptoms of chronic conditions , according to the largest poll of its kind. More than half (56 per cent) of those using cannabis for their conditions did so on a daily basis, with a further 23 per cent on a weekly basis. They write.

Conditions 45

Conditions Data Medicine Collective 45

WeedAdvisor

JULY 21, 2019

Marijuana may be a lucrative opportunity on the surface, but there are several conditions that could put the industry out of reach for some time. South America needs safe, reliable growing materials, cannot use certain pesticides, needs to meet cleanliness and safety standards, etc. Strict Regulations. .

Conditions 60

Conditions Seed-To-Sale Compliance Compliance 60

Veriheal

JANUARY 16, 2024

By focusing on this specific demographic, the team aimed to not only collect raw data but also gain insights into the motivations and experiences that led these caregivers to explore CBD as a therapeutic option for their children. Always consult a physician before making any decision on the treatment of a medical condition.

Patients 107

Patients CBD Treatment Research and Development 107

Cannabis Law Report

DECEMBER 2, 2021

The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. Alzheimer’s disease impacts about 50 million people worldwide and about 5.5 million individuals in the U.S.

Clinical Trials 52

Clinical Trials Data Patients THC 52

Cannabis Law Report

NOVEMBER 26, 2019

The FDA also published a revised Consumer Update detailing safety concerns about CBD products more broadly. This includes ongoing work to obtain and evaluate information to address outstanding questions related to the safety of CBD products, while maintaining the agency’s rigorous public health standards.

Safety 64

Safety Food CBD Oil 64

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

MAY 19, 2023

The review period will give employers a chance to identify safety-sensitive positions for which the new drug test ban is not appropriate. SB 5132 already has a number of exceptions built-in for safety-sensitive jobs like law enforcement, firefighting, and first responders. So, how exactly is ketamine able to do this?

Chronic Pain 79

Chronic Pain Data Consumption Safety 79

Cannabis Law Report

MAY 16, 2022

Data on injured workers from the nation’s most mature adult-use cannabis market is pretty boring. An analysis of workers’ comp claims from Pinnacol Assurance, Colorado’s largest workers’ compensation insurer, found few things that stood out in claims data from the state’s cannabis industry compared with other industries in the state.

Data 52

Data Strains Safety Cultivation 52

Veriheal

NOVEMBER 21, 2023

The buddie can be paired with a mobile app that tracks consumption, correlating it with health data from devices like WHOOP, Apple Watch, or Fitbit. Emphasizing data privacy, Maya’s innovation includes options to keep records on the user’s phone and easily delete data.

Research and Development 93

Research and Development Consumption Education Data 93

The Cannigma

OCTOBER 6, 2022

There is also an association with an increase in phlegm production, and a potential increase in certain respiratory conditions. Vaping may reduce tar exposure compared to smoke , but there are still concerns around the safety of oil vaporizers, especially after the EVALI crisis, which took dozens of American lives.

Vaping 90

Vaping Topical Data Safety 90

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 105

Consumption Patients Research and Development Data 105

Veriheal

MAY 30, 2023

Cancer Pain Relief With Cannabis: What the New Study Shows Utilizing data from the Quebec Cannabis Registry in Canada, researchers sought to examine the safety and effectiveness of cannabis in addressing cancer pain. Always consult a physician before making any decision on the treatment of a medical condition.

Medicine 96

Medicine Treatment Patients Data 96

Cannabis Law Report

MAY 26, 2022

Successful Behavioral Addiction Study Supplied Data for Patent. The successful completion of Awakn’s behavioral addictions study was announced last week and the data provided from the study was used in the patent filing. The treatment was also well tolerated with no safety concerns. Awakn Life Sciences Corp. (

Treatment 52

Treatment Research and Development Therapy Data 52

Cannabis Law Report

APRIL 1, 2022

The General Council of Pharmacists has proposed this Monday to carry out a pilot test in pharmacies to assess the use of cannabis for therapeutic purposes, a product that, in the opinion of the president of pharmacists, could have a similar use and conditions of use to those that have other compounds such as morphine.

Medicine 52

Medicine Data Safety Conditions 52

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

The Cannigma

FEBRUARY 2, 2021

Of these consumers, over half said the drug had a beneficial clinical effect on their condition. As medicinal cannabis treatments are now legal in many parts of the world, naturally, there is a growing interest in whether the products can treat neurological conditions like Parkinson’s disease. Parkinson’s disease and cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

AUGUST 10, 2021

The approval, made through the European Commission Decision Reliance Procedure (ECDRP), is based on data from a positive Phase 3 safety and efficacy study evaluating 25 mg/kg/day of GW’s cannabidiol. The safety profile observed was consistent with findings from previous studies, with no new safety risks identified.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

AUGUST 16, 2022

The New York State Cannabis Control Board (“CCB”) approved 15 Adult-Use Conditional Processor (“AUCP”) licenses during its public meeting today, adding a key link in the state’s budding adult-use cannabis supply chain. The application window for the adult-use cannabis conditional cultivator licenses closed on June 30, 2022.

Supply Chain 52

Supply Chain Conditions Cannabinoids Programs 52

Cannabis Law Report

JUNE 7, 2021

The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. This Phase 1 trial is currently testing IGC-AD1 for safety.

Clinical Trials 105

Clinical Trials Patients THC Safety 105

Cannabis Law Report

AUGUST 12, 2021

This regulative environment also promotes economic growth and significant medical benefits, boosting consumer safety and accessibility. In addition, cannabis for medical use will be exported abroad under the same conditions as other addictive substances. This could ultimately lead to a better pharmacy workflow and communication.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

Cannabis Law Report

AUGUST 27, 2021

The Rules aim to promote social equity, safety and easy access to the cannabis marketplace while keeping local municipalities in control of how they want cannabis businesses to operate in their jurisdiction. New applicants may apply for either a conditional license or an annual license.

Cultivation 105

Cultivation Conditions Business Cannabis 105

Cannabis Law Report

JUNE 16, 2021

This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. Training will be provided within the research program for licensed practitioners to assess the safety of psychedelic medicines and to classify and report positive and adverse events.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

The Cannigma

DECEMBER 20, 2021

terpenes ) may help treat a number of different skin conditions. Some of these have been identified as possible targets for the treatment of inflammatory skin conditions. Can cannabis make inflammatory skin conditions worse? The results were very positive and showed the safety and effectiveness of the topical CBD.

Terpenes 133

Terpenes Cannabinoids Topical Research and Development 133

Cannabis Law Report

OCTOBER 22, 2021

Cybin’s Research and Development team has completed 74 in-vitro and in-vivo evaluations of Cybin’s expanding portfolio of psychedelic compounds being designed for potential therapeutic applications for several mental health conditions.

Research and Development 52

Research and Development Safety Media Data 52

Canna Law Blog

DECEMBER 16, 2021

Psilocybin research license, which will allow the testing potency, conducting clinical investigations, researching efficacy and safety, and agricultural research. Expansive List of Qualifying Medical Conditions. Data from the RAND Corporation show that 8,000 New York veterans from the Wars in Iraq and Afghanistan suffer from PTSD.

Legislation 96

Legislation Treatment Therapy Conditions 96

Veriheal

NOVEMBER 18, 2022

According to the Texas Department of Public Safety Chief Wayne Muller, the state has averaged a 10% month-over-month increase in medical cannabis patients over the last 18 months. In September, the state expanded its list of qualifying conditions , allowing veterans with PTSD and cancer patients to join the program.

Edibles 86

Edibles Hemp Epilepsy Programs 86

Cannabis Law Report

DECEMBER 11, 2021

This reduction in prices will make the clinic the cheapest option for many patients looking to receive medical cannabis treatments for a wide variety of conditions and illnesses. Medical cannabis can be considered as a treatment for a number of conditions – including chronic pain, epilepsy, and insomnia – when first-line options have failed.

Access 52

Access Patients Chronic Pain Treatment 52

Canna Law Blog

JANUARY 17, 2023

A licensee automatically receives conditional approval after five days if a determination is still pending. Note: that link concerns the draft rule before the OLCC added the conditional approval “after five days” language to the proposed rule; but several other issues we identified remain in the rule as adopted).

Retail 70

Retail Cannabis Conditions Business 70

Cannabis Law Report

JUNE 16, 2021

Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols. Lobo brings a highly experienced and specialized team of technology experts in the fields of genetics, diagnostics, data and analytics, as well as a fully operational 5,000 sq. Vancouver, British Columbia–(Newsfile Corp.

Research and Development 105

Research and Development Data Conditions Events 105

The Cannigma

JUNE 15, 2021

However, the scientific data on CBG is nowhere near as developed as what we have on CBD. The vast majority of what we know about CBD’s medicinal effects is based on laboratory studies, is far from being properly understood, and lacks solid scientific data on human subjects — aside from epilepsy 5. Easy access. What’s in your CBD?

CBD 122

CBD Research and Development Epilepsy Extraction 122

Veriheal

DECEMBER 23, 2022

Dr. Maxwell’s team also collected data contained in samples sourced from California. After a close analysis of the data, the team determined that an absence of consistent federal guidelines regarding marijuana contaminants ultimately increases the risk of consumers developing health issues.

Research and Development 77

Research and Development Agriculture Data Extraction 77

SpeedWeed

MARCH 5, 2021

The investigators then performed an analysis of the data to quantify the relationships between lifetime cannabis use, 12-month cannabis use, and 12-month cannabis use frequency (at least monthly use and less than monthly use) and incidence of hypertension.

Blood Pressure 52

Blood Pressure Marijuana Data Therapy 52